| Issuer / Guarantor | Telix Pharmaceuticals Ltd |
|---|---|
| Size | USD 600mn |
| Type | Convertible |
| Leads | JP Morgan |
| Maturity | 22 Apr 2031 (5 years) |
| Coupon | 1.5% (1.5 - 1.75%) |
| Premium | 37.5% (35 - 37.5%) |
| Calls | @ 100% from May 2029 (3 yrs); 130% trigger |
| Puts | 3yrs @ 100% |
| Div protection | Ratio adjustment (Full) |
| T/o protection | c/t ratchet |
| CoCo | None |
| Announced | 14 Apr 2026 |